electroCore to Participate at Upcoming Investor Conferences
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in two major investor conferences in March 2025.
The company will attend the 37th Annual Roth Conference from March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California, where Chief Financial Officer Joshua Lev will host one-on-one meetings with investors.
Additionally, electroCore will participate in LSI USA '25 from March 17-21 at the Waldorf Astoria Monarch Beach Resort in Dana Point, California, where CFO Joshua Lev will manage the company's exhibition presence.
Interested investors can schedule meetings through their Roth or LSI representatives or by contacting FNK IR at ecor@fnkir.com.
electroCore (Nasdaq: ECOR), un'azienda di medicina bioelettronica e benessere in fase commerciale, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel marzo 2025.
L'azienda parteciperà al 37° Annual Roth Conference dal 16 al 18 marzo presso il Laguna Cliffs Marriott Resort & Spa a Dana Point, California, dove il Chief Financial Officer Joshua Lev ospiterà incontri individuali con gli investitori.
Inoltre, electroCore parteciperà a LSI USA '25 dal 17 al 21 marzo presso il Waldorf Astoria Monarch Beach Resort a Dana Point, California, dove il CFO Joshua Lev gestirà la presenza espositiva dell'azienda.
Gli investitori interessati possono programmare incontri tramite i loro rappresentanti Roth o LSI o contattando FNK IR all'indirizzo ecor@fnkir.com.
electroCore (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar en etapa comercial, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025.
La empresa asistirá a la 37ª Conferencia Anual Roth del 16 al 18 de marzo en el Laguna Cliffs Marriott Resort & Spa en Dana Point, California, donde el Director Financiero Joshua Lev llevará a cabo reuniones uno a uno con los inversores.
Además, electroCore participará en LSI USA '25 del 17 al 21 de marzo en el Waldorf Astoria Monarch Beach Resort en Dana Point, California, donde el CFO Joshua Lev gestionará la presencia de la empresa en la exposición.
Los inversores interesados pueden programar reuniones a través de sus representantes de Roth o LSI o contactando a FNK IR en ecor@fnkir.com.
electroCore (Nasdaq: ECOR), 상업 단계의 생체 전자 의학 및 웰니스 회사가 2025년 3월 두 개의 주요 투자자 회의에 참여한다고 발표했습니다.
회사는 3월 16일부터 18일까지 캘리포니아 다나 포인트의 라구나 클리프스 메리어트 리조트 & 스파에서 열리는 제37회 연례 로스 회의에 참석하며, 최고 재무 책임자인 조슈아 레브가 투자자와의 일대일 회의를 주최할 예정입니다.
또한 electroCore는 3월 17일부터 21일까지 캘리포니아 다나 포인트의 월도프 아스토리아 모나크 비치 리조트에서 열리는 LSI USA '25에 참여하며, CFO 조슈아 레브가 회사의 전시 존재를 관리할 것입니다.
관심 있는 투자자는 Roth 또는 LSI 대표를 통해 회의를 예약하거나 FNK IR에 ecor@fnkir.com으로 연락하여 일정을 잡을 수 있습니다.
electroCore (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être en phase commerciale, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025.
L'entreprise assistera à la 37e Conférence Annuelle Roth du 16 au 18 mars au Laguna Cliffs Marriott Resort & Spa à Dana Point, Californie, où le directeur financier Joshua Lev animera des réunions individuelles avec les investisseurs.
De plus, electroCore participera à LSI USA '25 du 17 au 21 mars au Waldorf Astoria Monarch Beach Resort à Dana Point, Californie, où le CFO Joshua Lev gérera la présence de l'entreprise à l'exposition.
Les investisseurs intéressés peuvent programmer des réunions par l'intermédiaire de leurs représentants Roth ou LSI ou en contactant FNK IR à l'adresse ecor@fnkir.com.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness in der kommerziellen Phase, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 bekannt gegeben.
Das Unternehmen wird an der 37. jährlichen Roth-Konferenz vom 16. bis 18. März im Laguna Cliffs Marriott Resort & Spa in Dana Point, Kalifornien, teilnehmen, wo der Chief Financial Officer Joshua Lev Einzelgespräche mit Investoren führen wird.
Zusätzlich wird electroCore an LSI USA '25 vom 17. bis 21. März im Waldorf Astoria Monarch Beach Resort in Dana Point, Kalifornien, teilnehmen, wo CFO Joshua Lev die Präsenz des Unternehmens auf der Ausstellung verwalten wird.
Interessierte Investoren können Meetings über ihre Roth- oder LSI-Vertreter oder durch Kontaktaufnahme mit FNK IR unter ecor@fnkir.com planen.
- None.
- None.
Management to Attend the 37th Annual Roth Conference and the LSI USA '25
ROCKAWAY, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in two upcoming investor conferences. Management will attend and engage with investors at:
- The 37th Annual Roth Conference March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California. Joshua Lev, Chief Financial Officer, will host one-on-one meetings at the conference.
- The LSI USA '25, March 17-21 at the Waldorf Astoria Monarch Beach Resort in Dana Point, California. Joshua Lev, Chief Financial Officer, will exhibit at the conference.
Investors attending these events who are interested in scheduling a meeting with management can do so by contacting their respective Roth or LSI representative, or by emailing FNK IR at ecor@fnkir.com for more information.
About the Roth Capital Partners Conference
The Annual ROTH Conference is one of the largest in the nation for small-cap companies, combining company presentations, Q&A sessions and management 1-on-1 meetings. The format provides investors the opportunity to hear from and meet with executive management from approximately 500 private and public companies in a variety of growth sectors. Roth’s award-winning Research Team identifies distinguished presenting companies across broad sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology and more.
About LSI
LSI is a team of industry insiders, market analysts, media professionals, and events strategists with a shared mission to save and improve lives through innovative medical technology — in the United States, and across the globe.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When and where is electroCore (ECOR) participating in the Roth Conference 2025?
What is the schedule for electroCore's (ECOR) participation in LSI USA '25?
Who will represent electroCore (ECOR) at these investor conferences?
How can investors schedule meetings with electroCore (ECOR) management at these conferences?
